Related Experiment Video
Updated: Aug 25, 2026
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
Published on: November 26, 2015
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays
Aruna V Krishnan1, Rajesh Shinghal, Nalini Raghavachari
1Department of Medicine, Stanford University School of Medicine, Stanford, California 94305-5103, USA.
Background:
1,25-dihydroxyvitamin D(3) [1,25(OH)2D3] exerts growth inhibitory, pro-differentiating, and pro-apoptotic effects on prostate cells. To better understand the molecular mechanisms underlying these actions, we employed cDNA microarrays to study 1,25(OH)2D3-regulated gene expression in the LNCaP human prostate cancer cells.
Methods:
mRNA isolated from LNCaP cells treated with vehicle or 50 nM 1,25(OH)2D3 for various lengths of time were hybridized to microarrays carrying approximately 23,000 genes. Some of the putative target genes revealed by the microarray analysis were verified by real-time PCR assays.
Results:
1,25(OH)2D3 most substantially increased the expression of the insulin-like growth factor binding protein-3 (IGFBP-3) gene. Our analysis also revealed several novel 1,25(OH)2D3-responsive genes. Interestingly, some of the key genes regulated by 1,25(OH)2D3 are also androgen-responsive genes. 1,25(OH)2D3 also down-regulated genes that mediate androgen catabolism.
Conclusions:
The putative 1,25(OH)2D3 target genes appear to be involved in a variety of cellular functions including growth regulation, differentiation, membrane transport, cell-cell and cell-matrix interactions, DNA repair, and inhibition of metastasis. The up-regulation of IGFBP-3 gene has been shown to be crucial in 1,25(OH)2D3-mediated inhibition of LNCaP cell growth. 1,25(OH)2D3 regulation of androgen-responsive genes as well as genes involved in androgen catabolism suggests that there are interactions between 1,25(OH)2D3 and androgen signaling pathways in LNCaP cells. Further studies on the role of these genes and others in mediating the anti-cancer effects of 1,25(OH)2D3 may lead to better approaches to the prevention and treatment of prostate cancer.
Insights
1,25-dihydroxyvitamin D(3) [1,25(OH)2D3] significantly impacts prostate cancer cells by regulating gene expression, notably increasing IGFBP-3. This vitamin D compound interacts with androgen signaling pathways, offering potential for new prostate cancer treatments.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Research
Background:
- 1,25-dihydroxyvitamin D(3) [1,25(OH)2D3] exhibits anti-cancer properties in prostate cells, including growth inhibition, differentiation induction, and apoptosis promotion.
- Understanding the molecular mechanisms of 1,25(OH)2D3 action in prostate cancer is crucial for therapeutic development.
Purpose of the Study:
- To investigate the gene expression profile regulated by 1,25(OH)2D3 in LNCaP human prostate cancer cells.
- To identify novel 1,25(OH)2D3-responsive genes and understand their role in prostate cancer progression.
Main Methods:
- Utilized cDNA microarrays to analyze gene expression changes in LNCaP cells treated with 1,25(OH)2D3.
- Verified key target genes identified through microarray analysis using real-time PCR.
Main Results:
- 1,25(OH)2D3 significantly upregulated the expression of insulin-like growth factor binding protein-3 (IGFBP-3).
- Identified several novel genes responsive to 1,25(OH)2D3, including those involved in androgen metabolism and androgen signaling pathways.
- Observed that some 1,25(OH)2D3-regulated genes are also androgen-responsive.
Conclusions:
- The identified 1,25(OH)2D3 target genes are implicated in diverse cellular functions relevant to cancer, such as growth regulation, differentiation, and metastasis inhibition.
- The upregulation of IGFBP-3 is critical for 1,25(OH)2D3's growth-inhibitory effects on LNCaP cells.
- Interactions between 1,25(OH)2D3 and androgen signaling pathways were suggested by the regulation of androgen-responsive genes and androgen catabolism genes, paving the way for novel therapeutic strategies.
